Conversion From Neoral (Cyclosporine) to Tacrolimus of Kidney Transplant Recipients for Gingival Hyperplasia or Hypertrichosis

By Busque S.   Demers P.   St-Louis G.   Boily J.-G.   Tousignant J.   Lemieux F.   Smeesters C.   Corman J.   Daloze P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1247-1248

Elsevier

Access to resources Recommend Favorite

Conversion From Cyclosporine Sandimmune to Cyclosporine Neoral in the Stable Renal Transplant Population

By Griffin P.J.A.   Moore R.H.   Jurewicz W.A.   Lord R.H.H.   Webley Y.   Jenkins J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 303-303

Elsevier

Access to resources Recommend Favorite

Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method

By First M.R.   Weiskittel P.   Shah M.   Peddi V.R.   Canafax D.   Schroeder T.J.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 3955-3957

Elsevier

Access to resources Recommend Favorite

Conversion from sandimmune to neoral in renal transplant recipients: two-year experience

By Wilczek H.E.   &   9kesson P.   Warholm C.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1753-1755

Elsevier

Access to resources Recommend Favorite

Conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients

By Zylber-Katz E.   Doron D.   Granot E.  

Transplantation Proceedings, Vol. 31, Iss. 4, 1999-06 ,pp. : 1915-1917

Elsevier

Access to resources Recommend Favorite